
pmid: 16533650
Nuchal translucency (NT) describes an echo-free area, below the skin, in the posterior nuchal and back region of the fetus and is typically observed in the first and early second trimester of pregnancy. A wide NT has been correlated with chromosomal and congenital abnormalities in the fetus. An accurate NT measurement is a critical component of the estimation of Down syndrome risk in the first trimester of pregnancy and the Nuchal Translucency Quality Review Program (NTQR) identified nine criteria that ensure an accurate measurement of NT during ultrasound examination. The purpose of this chapter is to present the technical aspects of obtaining an accurate NT measurement on ultrasound as outlined by the NTQR.
Chromosome Aberrations, Pregnancy Trimester, First, Pregnancy, Pregnancy Trimester, Second, Humans, Female, Credentialing, Down Syndrome, Nuchal Translucency Measurement, Congenital Abnormalities
Chromosome Aberrations, Pregnancy Trimester, First, Pregnancy, Pregnancy Trimester, Second, Humans, Female, Credentialing, Down Syndrome, Nuchal Translucency Measurement, Congenital Abnormalities
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 28 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
